Underdiagnosis of COPD: The Japan COPD Real-World Data Epidemiological (CORE) Study
DOI: https://doi.org/10.2147/copd.s450270
2024-05-07
International Journal of COPD
Abstract:Yuka Koga, 1 Sayaka Deguchi, 1 Takeshi Matsuo, 1 Akinori Suzuki, 1 Gen Terashima, 2 Takumi Tajima, 2 Yoko Shibata, 3 Hironori Sagara 4 1 Pharmaceutical Division, Pharmaceutical Company, Kracie, Ltd, Tokyo, Japan; 2 Real World Evidence Division, JMDC Inc, Tokyo, Japan; 3 Department of Pulmonary Medicine, Fukushima Medical University, Fukushima, Japan; 4 Department of Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan Correspondence: Yuka Koga, Pharmaceutical Division, Pharmaceutical Company, Kracie, Ltd, 3-20-20, Kaigan, Minato-ku, Tokyo, Japan, Tel +81 3-5446-3352, Fax +81 3-5446-3371, Email Purpose: The prevalence of airflow obstruction in Japan is 3.8%– 16.9%. This epidemiological study based on a large database aimed to reassess the prevalence of airflow obstruction in Japan and the diagnosis rate of chronic obstructive pulmonary disease (COPD). Patients and Methods: We used data regarding claims from the health insurance union and health checkups provided by JMDC. The present study included a subgroup of individuals aged ≥ 40 years who underwent health checkups involving spirometry between January and December 2019. The study endpoints were the prevalence of airflow obstruction, COPD diagnosis rate, disease stage, and respiratory function test results. Results: Among 102,190 participants, 4113 (4.0%) had airflow obstruction. The prevalence of airflow obstruction was 5.3% in men and 2.1% in women. Among the study population, 6.8% were current smokers, while 3.4% were never or former smokers. Additionally, the prevalence of COPD increased with age. Approximately 8.4% of participants with airflow obstruction were diagnosed with COPD. Regarding the COPD diagnosis status, participants with airflow obstruction who were diagnosed with COPD were at a more advanced stage than those not diagnosed. Finally, patients diagnosed with COPD had significantly lower FEV 1 /FVC and FEV 1 (p < 0.0001; Wilcoxon rank sum test). Conclusion: The epidemiological study based on a large database determined the COPD diagnosis rate related to airflow obstruction. The COPD diagnosis rate was extremely low among individuals who underwent health checkups, indicating the need for increased awareness about this medical condition. Moreover, primary care physicians should identify patients with suspected COPD and collaborate with pulmonologists to facilitate the early detection of COPD and enhance the COPD diagnosis rate. Keywords: COPD, epidemiology, airflow obstruction, prevalence, Japan, real-world data Chronic obstructive pulmonary disease (COPD) is defined as a lung disease caused by prolonged inhalation exposure to toxic substances, primarily tobacco smoke, and is characterized by airflow obstruction as indicated by respiratory function tests. Airflow obstruction results from a combination of peripheral airway involvement and emphysematous lesions in varying proportions. COPD is clinically characterized by slowly progressive dyspnea during exertion and a chronic cough with sputum; however, some patients may present mild to no symptoms. 1 According to a patient survey conducted by the Japanese Ministry of Health, Labour and Welfare (MHLW), 2 200,000 people in Japan are diagnosed with COPD, representing an estimated prevalence of 0.2%–0.4%. Contrastingly, the Nippon COPD Epidemiology (NICE) study 3 reported that 10.9% of the population aged ≥40 years had airflow obstruction and that the estimated prevalence of COPD in Japan is 8.6%, after excluding patients with asthma-related airflow obstruction. Further, among the participants with airflow obstruction, only 9.4% were diagnosed with COPD, indicating a low diagnosis rate. The NICE study was conducted in 2000; therefore, COPD-related circumstances, including demographic shifts such as population aging, alterations in smoking patterns, and changes in COPD prevalence, may have evolved after two decades. Health Japan 21 (the second term), which was initiated by the MHLW, has identified the need of increasing awareness regarding COPD. However, there remain limited public awareness regarding COPD despite respiratory function tests being performed during health checkups and screenings. 4 Currently, large databases of health insurance claims and health checkups are available, which facilitate the analysis of the prevalence, examination, and care of airflow obstruction and COPD. Accordingly, we aimed to reassess the current prevalence of airflow obstruction in Japan and to determine the COPD diagnosis rate. We analyzed data regarding health insurance claims and health ch -Abstract Truncated-
respiratory system